uniQure N.V. (QURE) Financials

QURE Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 831.7 million 624.0 million
2023-09-30 871.6 million 602.8 million
2023-06-30 942.8 million 589.4 million
2023-03-31 631.0 million 218.2 million

QURE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -51.6 million 7.0 million
2023-09-30 37.2 million 11.1 million
2023-06-30 -58.1 million 8.9 million
2023-03-31 -80.6 million 8.1 million

QURE Net Income

No data available :(

QURE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 617.9 million - 36.7 million
2023-09-30 658.9 million - 36.9 million
2023-06-30 628.6 million - 38.0 million
2023-03-31 315.3 million - 38.7 million

QURE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 47.8 million
2023-09-30 47.8 million
2023-06-30 47.6 million
2023-03-31 47.4 million

QURE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2.0 million 42.6 million 17.5 million -
2023-09-30 1.7 million 65.4 million 18.1 million -
2023-06-30 1.1 million 46.0 million 21.4 million -
2023-03-31 2.3 million 60.8 million 18.1 million -

QURE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 6.7 million 8.8 million
2023-09-30 1.4 million 1.0 million
2023-06-30 2.4 million 1.4 million
2023-03-31 5.3 million 2.4 million

QURE

Price: $4.53

52 week price:
4.53
22.48

Earnings Per Share: -6.47 USD

P/E Ratio: -1.11

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 380100

Ebitda: -8.2 million

Market Capitalization: 228.7 million

Links: